

Clinician-prescribed semaglutide and tirzepatide, as a weekly injection or a daily dissolving tablet. From $264/mo, everything included.
The lineup
Semaglutide or tirzepatide. A weekly injection or a daily dissolving tablet. Your clinician recommends the fit; you can switch later.


Dual-agonist strength
GLP-1 plus GIP. Two receptor pathways instead of one, which is why it posted the largest weight reduction of any approved medication in its class.



The proven GLP-1
The molecule that changed the category. Once a week, it quiets appetite signaling and slows gastric emptying so you eat less without deciding to.

Dual-agonist strength
GLP-1 plus GIP. Two receptor pathways instead of one, which is why it posted the largest weight reduction of any approved medication in its class.

Needle-free
The same GLP-1 in a tablet that dissolves under the tongue. For anyone who wants the mechanism without the needle.

Dual-agonist, no needle
Dual-pathway tirzepatide in a daily dissolving format. The most complete needle-free option we offer.
Trial figures from the STEP 1 (semaglutide 2.4 mg) and SURMOUNT-1 (tirzepatide 15 mg) studies of the brand-name medications alongside lifestyle changes. Compounded medications are not FDA-approved. Individual results vary.

In the body
GLP-1 receptors in the hypothalamus register fullness. With the signal amplified, the constant background hum of hunger fades and food noise drops. Most members notice this within the first two weeks.
Gastric emptying slows, so a normal portion keeps you satisfied for hours instead of minutes. You stop eating sooner, and you stay stopped.
Insulin release becomes glucose-dependent and glucagon is suppressed after meals. Fewer spikes, fewer crashes, fewer 4 p.m. cravings. Tirzepatide adds GIP signaling on top, which is where the extra loss comes from.
The first 90 days
Not a straight line. A steady, clinician-guided curve with a few landmarks you can expect along the way.
Week 1
Starting dose, usually in the evening. Some mild nausea is common as your body adjusts. Appetite starts to soften by the end of the week.
Weeks 2–4
The constant pull toward snacking quiets down. Portions shrink on their own. The scale usually starts to move here.
Weeks 5–8
Your clinician titrates based on how you feel and how you are responding. Most side effects have faded. Clothes start to fit differently.
Weeks 9–12
The medication is part of the week, not the whole week. Energy is up, cravings are down, and momentum is real.
Month 4 and on
Maintenance or continued titration, with check-ins whenever you want them. Trials show loss continuing well past a year.
Ranges are typical member-reported experiences and trial averages, not guarantees. Your clinician sets your titration schedule.
By the numbers
Semaglutide 2.4 mg at 68 weeks, STEP 1 trial.
Tirzepatide 15 mg at 72 weeks, SURMOUNT-1 trial.
From completed evaluation to a clinician decision.
Brand-name trial data · Individual results vary
The true cost
Compounded semaglutide and tirzepatide from licensed 503A pharmacies, with the clinician, supplies and shipping folded into one flat monthly price.
Included every month
Retail figures are published list prices and typical market rates; your insurance coverage may differ.
Pricing
Pick the molecule, pick the format. Medication, clinician care, supplies and shipping are one number, billed monthly after approval.
Weekly injection · −15% avg body weight, 68 weeks (STEP 1)
Risk-free: if you don't qualify, you don't pay.
Weekly injection · −21% avg body weight, 72 weeks (SURMOUNT-1)
Risk-free: if you don't qualify, you don't pay.
Members
“Twenty-two pounds in twelve weeks and, honestly, the bigger change is that I stopped thinking about food all day.”
“I switched from a med-spa paying almost double. Same medication, better follow-up, and it shows up at my door.”
“I was never going to inject myself. The tablet made it a non-issue, and I am down two sizes since spring.”
Member-reported experiences. Individual results vary and are not guaranteed.
Questions
Tirzepatide posted larger average weight loss in trials because it acts on two receptors, GLP-1 and GIP. Semaglutide has the longer track record and the lower price. Your clinician will recommend based on your history, goals and budget, and you can switch later.

Your first step
A private three-minute evaluation. A licensed clinician reviews it, usually within 72 hours. Medication ships cold to your door if prescribed.